CRONOS GROUP INC. Payments to Acquire Loans Receivable
CRONOS GROUP INC. (CRON) reported Payments to Acquire Loans Receivable of $13.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireLoansReceivable · last filed 2026-02-26
- CRONOS GROUP INC. payments to acquire loans receivable for the quarter ending 2025-12-31 was $0.00.
- CRONOS GROUP INC. payments to acquire loans receivable for the quarter ending 2025-09-30 was $13.31M.
- CRONOS GROUP INC. payments to acquire loans receivable for the quarter ending 2024-12-31 was -$63.00K.
- CRONOS GROUP INC. payments to acquire loans receivable for the quarter ending 2024-09-30 was -$14.00K.
- CRONOS GROUP INC. payments to acquire loans receivable for fiscal 2025 was $13.31M, a 51.92% increase from fiscal 2024.
- CRONOS GROUP INC. payments to acquire loans receivable for fiscal 2024 was $8.76M.
- CRONOS GROUP INC. payments to acquire loans receivable for fiscal 2023 was $0.00.
- CRONOS GROUP INC. payments to acquire loans receivable for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Loans Receivable 3 month | Payments to Acquire Loans Receivable 6 month | Payments to Acquire Loans Receivable 9 month | Payments to Acquire Loans Receivable 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.31M derived: sum of 2 quarters · filed 2026-02-26 | $13.31M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $13.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $13.31M 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$77.00K derived: sum of 2 quarters · filed 2026-02-26 | $8.76M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $8.82M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $8.84M 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2021-09-30 | $1.84M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18 | $4.26M derived: sum of 2 quarters · filed 2022-02-18 | $6.91M 10-Q · filed 2022-02-18 | $14.56M derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-06-30 | $2.42M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18 | $5.06M 10-Q/A · filed 2022-02-18 | $12.72M derived: sum of 3 quarters · filed 2022-05-10 | $25.74M derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-03-31 | $2.65M 10-Q · filed 2022-05-10 | $10.30M derived: sum of 2 quarters · filed 2022-05-10 | $23.32M derived: sum of 3 quarters · filed 2022-05-10 | $32.78M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $7.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $20.68M derived: sum of 2 quarters · filed 2022-02-18 | $30.14M derived: sum of 3 quarters · filed 2022-02-18 | $44.65M 10-K · filed 2021-02-26 |
| 2020-09-30 | $13.03M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18 | $22.49M derived: sum of 2 quarters · filed 2022-02-18 | $37.00M 10-Q · filed 2022-02-18 | $47.33M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $9.46M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18 | $23.97M 10-Q/A · filed 2022-02-18 | $34.30M derived: sum of 3 quarters · filed 2022-02-18 | $55.09M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $14.51M 10-Q · filed 2021-05-07 | $24.84M derived: sum of 2 quarters · filed 2021-05-07 | $45.63M derived: sum of 3 quarters · filed 2021-05-07 | $57.85M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $10.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $31.11M derived: sum of 2 quarters · filed 2021-02-26 | $43.34M derived: sum of 3 quarters · filed 2021-02-26 | $43.34M 10-K · filed 2021-02-26 |
| 2019-09-30 | $20.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $33.01M derived: sum of 2 quarters · filed 2020-11-05 | $33.01M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $12.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $12.22M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $0.00 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |